Artykuły udostępnione publicznie: - Jaya PadmanabhanWięcej informacji
Niedostępne w żadnym miejscu: 2
Strategies for advancing disease definition using biomarkers and genetics: the bipolar and schizophrenia network for intermediate phenotypes
CA Tamminga, GD Pearlson, AD Stan, RD Gibbons, J Padmanabhan, ...
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2 (1), 20-27, 2017
Upoważnienia: US National Institutes of Health
Brain structural abnormalities, social function and psychopathology in schizophrenia
J Padmanabhan, CI Hooker, MS Keshavan
Brain Evolution, Language and Psychopathology in Schizophrenia, 135-150, 2013
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 27
A human depression circuit derived from focal brain lesions
JL Padmanabhan, D Cooke, J Joutsa, SH Siddiqi, M Ferguson, RR Darby, ...
Biological psychiatry 86 (10), 749-758, 2019
Upoważnienia: US National Institutes of Health, Academy of Finland
Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease
SH Siddiqi, FL Schaper, A Horn, J Hsu, JL Padmanabhan, A Brodtmann, ...
Nature human behaviour 5 (12), 1707-1716, 2021
Upoważnienia: US National Institutes of Health
Correlations between brain structure and symptom dimensions of psychosis in schizophrenia, schizoaffective, and psychotic bipolar I disorders
JL Padmanabhan, N Tandon, CS Haller, IT Mathew, SM Eack, ...
Schizophrenia bulletin 41 (1), 154-162, 2015
Upoważnienia: US National Institutes of Health
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
T Miyagawa, D Brushaber, J Syrjanen, W Kremers, J Fields, LK Forsberg, ...
Alzheimer's & Dementia 16 (1), 106-117, 2020
Upoważnienia: US National Institutes of Health
Recent advances in understanding schizophrenia
CS Haller, JL Padmanabhan, P Lizano, J Torous, M Keshavan
F1000prime reports 6, 57, 2014
Upoważnienia: US National Institutes of Health
The “polyenviromic risk score”: aggregating environmental risk factors predicts conversion to psychosis in familial high-risk subjects
JL Padmanabhan, JL Shah, N Tandon, MS Keshavan
Schizophrenia research 181, 17-22, 2017
Upoważnienia: US National Institutes of Health, Fonds de recherche du Québec - Santé
Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls
R Shafee, P Nanda, JL Padmanabhan, N Tandon, N Alliey-Rodriguez, ...
Translational psychiatry 8 (1), 78, 2018
Upoważnienia: US National Institutes of Health
Dysplasticity, metaplasticity, and schizophrenia: implications for risk, illness, and novel interventions
MS Keshavan, UM Mehta, JL Padmanabhan, JL Shah
Development and psychopathology 27 (2), 615-635, 2015
Upoważnienia: US National Institutes of Health
Use of the CDR® plus NACC FTLD in mild FTLD: data from the ARTFL/LEFFTDS consortium
T Miyagawa, D Brushaber, J Syrjanen, W Kremers, J Fields, LK Forsberg, ...
Alzheimer's & Dementia, 2019
Upoważnienia: US National Institutes of Health, Canadian Institutes of Health Research
Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
JL Adams, T Kangarloo, B Tracey, P O’Donnell, D Volfson, RD Latzman, ...
npj Parkinson's Disease 9 (1), 64, 2023
Upoważnienia: US National Institutes of Health, Patient-Centered Outcomes Research …
Impulsivity across the psychosis spectrum: correlates of cortical volume, suicidal history, and social and global function
P Nanda, N Tandon, IT Mathew, JL Padmanabhan, BA Clementz, ...
Schizophrenia research 170 (1), 80-86, 2016
Upoważnienia: US National Institutes of Health
Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders
SS Mothi, N Tandon, J Padmanabhan, IT Mathew, B Clementz, ...
Schizophrenia research 165 (1), 103-107, 2015
Upoważnienia: US National Institutes of Health
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint
AM Staffaroni, L Bajorek, KB Casaletto, Y Cobigo, SYM Goh, A Wolf, ...
Alzheimer's & Dementia 16 (1), 11-21, 2020
Upoważnienia: US Department of Defense, US National Institutes of Health, Canadian …
Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
AM Staffaroni, Y Cobigo, SYM Goh, J Kornak, L Bajorek, K Chiang, ...
Alzheimer's & Dementia 16 (1), 37-48, 2020
Upoważnienia: US Department of Defense, US National Institutes of Health, Canadian …
Motor cortical plasticity in schizophrenia: A meta-analysis of Transcranial Magnetic Stimulation–Electromyography studies
UM Mehta, MV Thanki, J Padmanabhan, A Pascual-Leone, MS Keshavan
Schizophrenia research 207, 37-47, 2019
Upoważnienia: US National Institutes of Health, Wellcome Trust/DBT India Alliance
NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis
N Alliey-Rodriguez, TA Grey, R Shafee, H Asif, O Lutz, NR Bolo, ...
Translational psychiatry 9 (1), 230, 2019
Upoważnienia: US National Institutes of Health
Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives
JL Padmanabhan, P Nanda, N Tandon, SS Mothi, N Bolo, S McCarroll, ...
Journal of psychiatric research 77, 52-58, 2016
Upoważnienia: US National Institutes of Health
Nonlinear Z‐score modeling for improved detection of cognitive abnormality
J Kornak, J Fields, W Kremers, S Farmer, HW Heuer, L Forsberg, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11 (1 …, 2019
Upoważnienia: US Department of Defense, US National Institutes of Health, Canadian …
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy